Statistics
Publications
126
Citations
13.7K
H-Index
47
Active since
1985
Neil P. Shah is an author at University of California, San Francisco specializing in medicine, pharmacology, and oncology.
Publications per year
1985–2024
126
126
Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Neil P. Shah, Chris Tran, Francis Y. Lee et al. · Science · 2004 · 1.8K citations
Medicine, Oncology, Pharmacology +14
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Dynamics of chronic myeloid leukaemia
Franziska Michor, Timothy P. Hughes, Yoh Iwasa et al. · Nature · 2005 · 850 citations
Medicine, Hematology, Oncology +12
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Catherine C. Smith, Qi Wang, Chen-Shan Chin et al. · Nature · 2012 · 745 citations
Medicine, Genetics, Hematology +13
1–5 of 126